je.st
news
Merck Congratulates Ecuador as Second Country to Receive PAHO/WHO Verification of Elimination of River Blindness
2014-10-03 15:00:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, applauds the government of Ecuador on being the second country in the world to receive World Health Organization (WHO) verification of the elimination of river blindness (onchocerciasis) using MECTIZAN (ivermectin). Language: English Contact: MerckJennifer Woodruff, 267-305-3550 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: country
receive
river
ecuador
Category:Biotechnology and Pharmaceuticals